Hematologia
Kliiniset tulokset
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial. (avaa uuden ikkunan)
Lähde: Lancet Haematol 2018;5(3):e117-e126.
Arkistoitu: PubMed 29396092
DOI: 10.1016/S2352-3026(18)30016-4
https://www.ncbi.nlm.nih.gov/pubmed/29396092 (avaa uuden ikkunan)
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (avaa uuden ikkunan)
Lähde: Cancer 2013;119(1):107-14.
Arkistoitu: PubMed 22744794
DOI: 10.1002/cncr.27686
https://www.ncbi.nlm.nih.gov/pubmed/22744794 (avaa uuden ikkunan)